Simple blood test could replace risky biopsies for transplant patients

NCT ID NCT02423070

Recruiting now Diagnosis Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Source: ClinicalTrials.gov ↗

Summary

This study is testing a new blood test to detect early signs of organ rejection in people who have received a heart or lung transplant. The test looks for tiny pieces of DNA from the donor organ in the patient's blood, which may signal rejection before serious damage occurs. Researchers hope this non-invasive method can replace the need for frequent, painful tissue biopsies and help doctors treat problems sooner.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

INOVA Fairfax Medical
RECRUITING

Falls Church, Virginia, 22042, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Johns Hopkins University
RECRUITING

Baltimore, Maryland, 21218, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
MedStar Washington Hospital Center
COMPLETED

Washington D.C., District of Columbia, 20010, United States
National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Maryland
TERMINATED

Baltimore, Maryland, 21228, United States
Virginia Commonwealth University
ACTIVE_NOT_RECRUITING

Richmond, Virginia, 23284, United States

Conditions

Explore the condition pages connected to this study.

THORACIC ORGAN TRANSPLANTATION